Published

[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?]

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2024-12-30
Source: Europe PMC
DOI: Unavailable
PubMed: 42412648

Authors

Papp N Gonda X.

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Emotional Processing Clinical Trial Review Article Animal Study Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-01 Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challengesJournal of Psychiatric Research · 2026-06-22 Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARASAIMSARA Journal · 2026-06-14 Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic ReviewJournal of Clinical Psychology · 2026-06-14 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-28 Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-08-31 Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open Science Framework · 2026-07-07 Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".PLoS ONE · 2026-06-29